Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approach. - Papathanasiou T; Strathe A; Agersø H; Lund TM; Overgaard RV (Diabetes, obesity & metabolism, 2020)